当前位置: 首页 > 期刊 > 《医学信息》 > 201433
编号:13665868
a维生素B6预防5—氟尿嘧啶导致手足综合征的临床观察(2)
http://www.100md.com 2014年8月20日 《医学信息》 201433
     参考文献:

    [1]SAIF M W,KATIRTZOGLOU N A,SYRIGOS K N.Capeeitabine:an overview of the side efects and their management[J].Antican-cerDrugs,2008,19(5):447-464.

    [2]沈婕,何胜利,孙贤俊,等.老年晚期胃癌患者卡培他滨节律化疗的临床疗效[J].肿瘤,2010,30(9):788-90.

    [3]DISEL U,GaRKUT O,ABAu H,et a1.Unilateral hand-foot syndrome:an extraordinary side efect of capecitabine[J].Cutan Ocul Toxicol,2010,29(2):140-142.

    [4]LOKICK J J,MOORE C.Chemotherapy-associated palmar-plantar erythrodysesthesia syndrome[J].Ann Intern Med,1984,101(6):798-799.

    [5]Duschinsky R,Pleven E.The synthesis of 5-fluoropyrimIdinesf[J].Journal of the American Chemical Society,1957,79(6):4559-4560.

    [6]王涛,江泽飞,宋三泰,等.希罗达治疗乳腺癌所致手足综合征的发生规律及临床处理[J].癌症进展,2004,2(4):258-261.

    [7]MILANO G,ETIENNE GRIMALDI M C,MARI M,et a1.Candi-date mechanisms for capecitabine-related hand-foot syndrome[J].Br J Clin Pharmacol,2008,66(1):88-95.

    [8]Gressett SM,Stanford BI,Hardwicke F. Management of hand-foot syndrome induced by capecitabine[J].J Oncol Pharm Pract,2006,12(3):131-141.

    编辑/申磊, 百拇医药(朱红军 陈萍)
上一页1 2